Technology Assisted Stepped Collaborative Care Intervention
Status: | Recruiting |
---|---|
Conditions: | Renal Impairment / Chronic Kidney Disease |
Therapuetic Areas: | Nephrology / Urology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/8/2019 |
Start Date: | March 28, 2018 |
End Date: | December 2022 |
Contact: | Manisha Jhamb, MD |
Email: | jhambm@upmc.edu |
Phone: | 412-647-7062 |
Technology Assisted Stepped Collaborative Care Intervention (TASCCI) to Improve Patient-centered Outcomes in Hemodialysis Patients
This study evaluates a collaborative care intervention in reducing depression, fatigue and
pain symptoms and improving health related quality of life in hemodialysis patients. Half of
participants will receive the collaborative care intervention, while the other half will
receive technology delivered health education information.
pain symptoms and improving health related quality of life in hemodialysis patients. Half of
participants will receive the collaborative care intervention, while the other half will
receive technology delivered health education information.
End-stage renal disease patients on hemodialysis experience substantial symptom burden with
fatigue, pain and depression among the most debilitating and existing as symptom clusters.
These symptom clusters can exacerbate one another, and are independent and strong predictors
of poor health-related quality of life in hemodialysis patients. This study will look at the
effect of a 12 week stepped care intervention on changes in depression, pain or fatigue and
health related quality of life.
fatigue, pain and depression among the most debilitating and existing as symptom clusters.
These symptom clusters can exacerbate one another, and are independent and strong predictors
of poor health-related quality of life in hemodialysis patients. This study will look at the
effect of a 12 week stepped care intervention on changes in depression, pain or fatigue and
health related quality of life.
Inclusion Criteria:
1. 18 years or older
2. undergoing thrice-weekly maintenance hemodialysis for > 3 months
3. English speaking
4. able to provide informed consent
5. no evidence of thought disorder, delusions or active suicidal ideation
Exclusion Criteria:
1. thought disorder, delusions or active suicidal ideation
2. active substance abuse
3. too ill or cognitively impaired to participate based on clinicians' judgment
4. anticipated life expectancy of less than 1 year
5. unable or unwilling to adhere to study protocol
6. participating in another clinical trial or taking an investigational drug
7. scheduled for living donor kidney transplant within next 6 months
8. relocating to another dialysis unit within 6 months
We found this trial at
1
site
4200 Fifth Ave
Pittsburgh, Pennsylvania 15260
Pittsburgh, Pennsylvania 15260
(412) 624-4141
Phone: 412-647-7062
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
Click here to add this to my saved trials